Pauline Vetter

7PUBLICATIONS
11CO-AUTHORS
Innate immunityMedical virologyApplied immunology (incl. antibody engineering, xenotransplantation and t-cell therapies)Predictive and prognostic markersEpidemiological modelling
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (7)

|Mar 27, 2026
Use of baloxavir as adjunctive antiviral therapy to neuraminidase inhibitors in severely immunocompromised individuals infected with influenza.

Pauline Vetter, Ana Rita Goncalves Cabecinhas, Manuel Schibler

|Nov 25, 2025
Antiviral treatment in adult patients hospitalized for influenza: study protocol for a multi-center, randomized, placebo-controlled trial on the efficacy of baloxavir marboxil to reduce time to clinical improvement and the risk for severe complications (the INFLUENT trial).

Krisztina Hosszu-Fellous, Antoine Poncet, Ana Rita Goncalves Cabecinhas

|Dec 14, 2023
Hepatitis E Virus Infection Epidemiology in Recipients of Allogeneic Hematopoietic Cell Transplant.

Johan Courjon, Vera Portillo, Sabine Yerly

|Dec 15, 2022
Prevalence of Post-Coronavirus Disease Condition 12 Weeks After Omicron Infection Compared With Negative Controls and Association With Vaccination Status.

Mayssam Nehme, Pauline Vetter, François Chappuis

|Apr 08, 2022
Infectious viral load in unvaccinated and vaccinated individuals infected with ancestral, Delta or Omicron SARS-CoV-2.

Olha Puhach, Kenneth Adea, Nicolas Hulo

|Jun 15, 2021
Feasibility and safety of rVSV-ZEBOV vaccination of humanitarian health workers against Ebola virus disease: an observational study.

Luisa Carnino, Pauline Vetter, Nicolas Peyraud

Pageof 2

Frequent Collaborators

1 joint publications

Gilles Eperon

1 joint publications

Olha Puhach

1 joint publications

Frédérique Jacquérioz

1 joint publications

Laurent Kaiser